The provided text discusses the safety and tolerability profile of the compound CMS121, drawing information from preclinical animal studies and a completed Phase I clinical trial in healthy human subjects. Animal studies indicated no significant adverse effects...
Stay Ahead.
Subscribe for Expert Insights.
You can unsubscribe at any time using the link in the footer of our emails. View our Privacy Policy.